Aplenzin 522 mg/1 (Bupropion Hydrobromide TABLET, EXTENDED RELEASE) 522 mg/1

Aplenzin 522 mg is an extended-release tablet containing bupropion hydrobromide, used for depression and seasonal affective disorder. Learn about its uses, effects, and precautions.

Strength

522 mg/1

Pack Size

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5812-30)

Manufacturer / TM Owner

Bausch Health US, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Aplenzin 522 mg is primarily used for managing major depressive disorder and seasonal affective disorder. Bupropion hydrobromide, the active ingredient, is an antidepressant that works by affecting certain chemicals in the brain. This medication is often prescribed when other treatments have not been effective or have caused unwanted side effects. What is Aplenzin used for? It is typically used to improve mood, sleep, appetite, and energy levels in individuals suffering from these conditions.

Side Effects

Common effects of Aplenzin 522 mg may include dry mouth, nausea, dizziness, and insomnia. Some users might experience headaches or constipation. These effects vary among individuals and are not experienced by everyone. If any effects persist or worsen, it is advisable to consult a healthcare professional.

Precautions & Warnings

Aplenzin 522 mg should be handled with care. It is important to follow the prescribed dosage and administration instructions. This medication may cause drowsiness or dizziness, so it is advisable to avoid driving or operating heavy machinery until you know how it affects you. Additionally, alcohol should be avoided while taking this medication.

Avoid Interactions

Aplenzin 522 mg may interact with other medications, including those that affect the central nervous system, such as antidepressants, antipsychotics, and sedatives. It is also important to be cautious when taking this medication with alcohol or other substances that can cause drowsiness. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.

Frequently Asked Questions

Aplenzin 522 mg is used for managing major depressive disorder and seasonal affective disorder.

Aplenzin 522 mg should be taken orally, usually once daily, with or without food. Follow the instructions provided by your healthcare professional.

Common side effects may include dry mouth, nausea, dizziness, and insomnia. If these effects persist or worsen, consult your healthcare provider.

It is advisable to avoid alcohol while taking Aplenzin 522 mg, as it may increase the risk of side effects.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.